We looked at AbbVie (ABBV) back on May 14 and anticipated that "The charts and indicators of ABBV are bullish and pointed higher. Stay long. Raise stops to $106. Our price targets are now the $132-$143 area with $225 longer-term."
It has taken longer than anticipated but ABBV has broken on to a new high. Let's review the charts again.